Gujarat is playing a vital role in India’s pharmaceutical industry, driven by government initiatives and investment opportunities. The state is home to major pharmaceutical companies such as Sun Pharma, Zydus Cadila, and Intas Pharmaceuticals, contributing significantly to the country’s pharmaceutical output. The North Gujarat region, in particular, accounts for 12% of the state’s pharmaceutical manufacturing, making it a crucial hub for the industry.
Mehsana is a notable location in North Gujarat, offering substantial prospects in bulk drug production, Active Pharmaceutical Ingredients (APIs), intermediates, and formulations. Torrent Pharma, a prominent company in the region, operates a USFDA-approved facility, producing insulin for Novo Nordisk, making it India’s sole contract manufacturer of insulin for the company. This highlights the region’s capabilities in producing high-quality pharmaceutical products.
Patan, another district in North Gujarat, is also making significant contributions to the pharmaceutical sector, with a strong base of micro, small, and medium enterprises (MSMEs) specializing in injectables and formulations. The district is also gaining traction in the MedTech sector, with companies producing vascular interventional devices and medical equipment, such as hospital trolleys. The region’s educational institutions support this growth, with a focus on healthcare and pharmaceutical education.
The region’s comprehensive healthcare network, comprising 318 Primary Health Centres and 75 Community Health Centres, provides robust healthcare services across government and private sectors. This network is expected to be further strengthened by the forthcoming Vibrant Gujarat Regional Conference (VGRC), which aims to foster collaboration among the government, industry, and academia. The conference is expected to have a significant impact on the pharmaceutical sector’s trajectory, driving growth and innovation in the region.
Overall, North Gujarat is poised to become a major hub for the pharmaceutical industry, driven by government support, investment opportunities, and a strong network of educational institutions and healthcare services. The region’s potential for growth and innovation is significant, and the forthcoming VGRC is expected to play a key role in shaping the sector’s future. With its strong foundation in pharmaceutical manufacturing, North Gujarat is well-positioned to contribute to India’s growing pharmaceutical industry.